| Target Price | $17.19 |
| Price | $15.64 |
| Potential |
9.89%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Sotera Health Co 2026 .
The average Sotera Health Co target price is $17.19.
This is
9.89%
register free of charge
$22.05
40.98%
register free of charge
$15.15
3.13%
register free of charge
|
|
| A rating was issued by 12 analysts: 8 Analysts recommend Sotera Health Co to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sotera Health Co stock has an average upside potential 2026 of
9.89%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.10 | 1.17 |
| 4.87% | 6.23% | |
| EBITDA Margin | 32.68% | 50.66% |
| 0.72% | 55.00% | |
| Net Margin | 4.03% | 19.30% |
| 17.25% | 378.99% |
9 Analysts have issued a sales forecast Sotera Health Co 2025 . The average Sotera Health Co sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Sotera Health Co EBITDA forecast 2025. The average Sotera Health Co EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Sotera Health Co Analysts have issued a net profit forecast 2025. The average Sotera Health Co net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.16 | 0.79 |
| 11.11% | 393.75% | |
| P/E | 19.70 | |
| EV/Sales | 5.46 |
9 Analysts have issued a Sotera Health Co forecast for earnings per share. The average Sotera Health Co EPS is
This results in the following potential growth metrics and future valuations:
Sotera Health Co...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BMO Capital |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 02 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Jun 24 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | May 05 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BMO Capital:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 02 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jun 24 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


